New Zealand markets closed

Sabra Health Care REIT, Inc. (SBRA)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
14.49-0.38 (-2.56%)
At close: 04:00PM EDT
14.60 +0.11 (+0.76%)
After hours: 06:10PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 3.36B
Enterprise value 5.79B
Trailing P/E 69.05
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)5.18
Price/book (mrq)1.21
Enterprise value/revenue 8.87
Enterprise value/EBITDA 17.17

Trading information

Stock price history

Beta (5Y monthly) N/A
52-week change 325.24%
S&P500 52-week change 326.43%
52-week high 314.92
52-week low 310.30
50-day moving average 314.13
200-day moving average 313.77

Share statistics

Avg vol (3-month) 32.05M
Avg vol (10-day) 32.07M
Shares outstanding 5231.5M
Implied shares outstanding 6237.4M
Float 8229.01M
% held by insiders 11.14%
% held by institutions 194.38%
Shares short (15 Apr 2024) 411.34M
Short ratio (15 Apr 2024) 46.2
Short % of float (15 Apr 2024) 47.06%
Short % of shares outstanding (15 Apr 2024) 44.90%
Shares short (prior month 15 Mar 2024) 412.39M

Dividends & splits

Forward annual dividend rate 41.2
Forward annual dividend yield 48.28%
Trailing annual dividend rate 30.90
Trailing annual dividend yield 36.05%
5-year average dividend yield 49.05
Payout ratio 4571.43%
Dividend date 329 Feb 2024
Ex-dividend date 412 Feb 2024
Last split factor 21:3
Last split date 316 Nov 2010

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Mar 2024

Profitability

Profit margin 7.61%
Operating margin (ttm)34.83%

Management effectiveness

Return on assets (ttm)2.59%
Return on equity (ttm)1.72%

Income statement

Revenue (ttm)650.04M
Revenue per share (ttm)2.81
Quarterly revenue growth (yoy)3.90%
Gross profit (ttm)N/A
EBITDA 393.66M
Net income avi to common (ttm)49.5M
Diluted EPS (ttm)0.21
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)59.93M
Total cash per share (mrq)0.26
Total debt (mrq)2.46B
Total debt/equity (mrq)89.02%
Current ratio (mrq)4.33
Book value per share (mrq)11.95

Cash flow statement

Operating cash flow (ttm)285.08M
Levered free cash flow (ttm)-169.7M